Generium And Selexis Debut Dornase Alfa In Russia

 
• By Dave Wallace

Generium is claiming the launch of the world’s first biosimilar version of Roche’s Pulmozyme after receiving approval for dornase alfa in Russia.

Dornase_Alfa
Generium And Selexis Are Claiming The World’s First Dornase Alfa Biosimilar • Source: Shutterstock

More from Biosimilars

More from Products